Mortality in hospitalized patients with cancer and coronavirus disease 2019: a systematic review and meta‐analysis of cohort studies

A Desai, R Gupta, S Advani, L Ouellette, NM Kuderer… - Cancer, 2021 - Wiley Online Library
Background Heterogeneous evidence exists on the effect of coronavirus disease 2019
(COVID‐19) on the clinical outcomes of patients with cancer. Methods A systematic review …

Radiotherapy based management during Covid-19 pandemic–A systematic review of presented consensus and guidelines

Z Siavashpour, N Goharpey, M Mobasheri - Critical Reviews in Oncology …, 2021 - Elsevier
Abstract Treatment management of cancer patients in the radiation oncology departments
during the current COVID-19 pandemic is challenging. A systematic review of published …

[HTML][HTML] Associations of mthfr rs1801133 (677c> t) and rs180113 (1298a> c) polymorphisms with susceptibility to bladder cancer: A systematic review and meta …

S Farshid, A Alijanpour, M Barahman… - Asian Pacific Journal …, 2022 - ncbi.nlm.nih.gov
The effects of the MTHFR rs1801133 (677C> T) and rs180113 (1298A> C) polymorphisms
on bladder cancer risk have been evaluated in some studies. However, the results were …

Effect of antitumor therapy on cancer patients infected by SARS‐CoV‐2: a systematic review and meta‐analysis

P Li, L Li, S Wang, Y Liu, Z Li, S Xia - Cancer Medicine, 2021 - Wiley Online Library
Background Cancer patients are at a high risk of being infected with severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2), and are more likely to develop severe illness and …

Navigating the COVID-19 Therapeutic Landscape: Unveiling Novel Perspectives on FDA-Approved Medications, Vaccination Targets, and Emerging Novel Strategies

R Barghash, D Gemmati, AM Awad, MMM Elbakry… - 2024 - preprints.org
Amidst the ongoing global challenge of the SARS-CoV-2 pandemic, the quest for effective
antiviral medications remains paramount. This comprehensive review delves into the …

Evaluating laboratory parameters of COVID-19 cases with underlying chronic diseases

ME Demirkol, M Kaya, S Özsarı… - Journal of Istanbul Faculty …, 2021 - dergipark.org.tr
Objective: COVID-19 infection caused by the SARS-CoV-2 which was initially detected in
China during the last days of 2019 has spread to the whole world in a short period of time …

[HTML][HTML] Early COVID-19 Hospitalizations Among New York State Residents with a History of Invasive Cancer

X Zhang, MG Kuliszewski, AR Kahn… - Journal of Registry …, 2022 - ncbi.nlm.nih.gov
Background: Individuals with a history of cancer may be more susceptible to severe COVID-
19 due to immunosuppression, comorbidities, or ongoing treatment. We linked inpatient …

[PDF][PDF] Journal of Clinical Images and Medical Case Reports

Z Mehrabi, S Haghighat, SA Zomorodian - 2023 - jcimcr.org
Background: A novel coronavirus known as severe acute respiratory syndrome coronavirus2
(SARS-CoV2) discovered in late December 2019 in China and spread across the world …

[HTML][HTML] Successful treatment of advanced prostate cancer patient with moderate to severe COVID-19 infection: A case report and review of the literature

Z Mehrabi, S Haghighat, SA Zomorodian - jcimcr.org
Background: A novel coronavirus known as severe acute respiratory syndrome coronavirus2
(SARS-CoV2) discovered in late December 2019 in China and spread across the world …

Risco de COVID-19 em doentes oncológicos

AR Carreira - 2021 - repositorio.ul.pt
A COVID-19 é a doença provocada pelo novo coronavírus SARS-CoV-2, identificado pela
primeira vez no final de 2019, na cidade chinesa de Wuhan. Esta doença, que pode causar …